FDA Reveals Why It Changed End Date of Study of Heart Inflammation After COVID Vaccination

The Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/Reuters

The U.S. Food and Drug Administration (FDA) changed the end date of a study it is requiring Pfizer to conduct because Pfizer requested a delay, the agency says.

“The company requested an extension from FDA for completion, which the agency granted,” an FDA spokesperson told The Epoch Times via email.